pharma · Carcinoma, Non-small-cell Lung · Type 2 Diabetes Mellitus · LGND
LIGAND PHARMACEUTICALS
LIGAND PHARMACEUTICALS INC
LIGAND PHARMACEUTICALS clinical programs — 22 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 555 Heritage Dr, Suite 200, Jupiter, Florida 33458, US
- Founded
- 1987
- Employees
- 130
- Programs
- 34
- Drugs
- 25
- Patents
- 133
LIGAND PHARMACEUTICALS projects
22 ClinicalTrials.gov programs sponsored by LIGAND PHARMACEUTICALS.
LIGAND PHARMACEUTICALS has 22 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Alitretinoin
LIGAND PHARMACEUTICALS INC
Sarcoma, Kaposi
2 trials -
Aplindore
LIGAND PHARMACEUTICALS INC
Restless Legs Syndrome
1 trial -
Aplindore
LIGAND PHARMACEUTICALS INC
Early Stage Parkinson's Disease
1 trial -
Bexarotene
LIGAND PHARMACEUTICALS INC
Lung Cancer
1 trial -
Bexarotene
LIGAND PHARMACEUTICALS INC
Sarcoma, Kaposi
1 trial -
Bexarotene (targretin)
LIGAND PHARMACEUTICALS INC
Carcinoma, Non-small-cell Lung
1 trial -
Bexarotene 1% gel
LIGAND PHARMACEUTICALS INC
Parapsoriasis
1 trial -
Bexarotene/NBUVB vs placebo NBUVB
LIGAND PHARMACEUTICALS INC
Psoriasis
1 trial -
Budesonide
LIGAND PHARMACEUTICALS INC
Seasonal Allergic Rhinitis
1 trial -
Budesonide + Azelastine
LIGAND PHARMACEUTICALS INC
Seasonal Allergic Rhinitis
1 trial -
CE-Iohexol
LIGAND PHARMACEUTICALS INC
Contrast-induced Nephropathy
1 trial -
LGD-6972-5 mg
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
Lasofoxifene
LIGAND PHARMACEUTICALS INC
Bone Loss
1 trial -
MB07133 300mg/m2/day
LIGAND PHARMACEUTICALS INC
Hepatocellular Carcinoma
1 trial -
MB07803
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
MB07811
LIGAND PHARMACEUTICALS INC
Hypercholesterolemia
1 trial -
PS433540
LIGAND PHARMACEUTICALS INC
Hypertension
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Cutaneous T-Cell Lymphoma
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Breast Cancer
1 trial -
denileukin diftitox
LIGAND PHARMACEUTICALS INC
Drug/Agent Toxicity by Tissue/Organ
1 trial -
erlotinib and bexarotene
LIGAND PHARMACEUTICALS INC
Carcinoma, Non-small-cell Lung
1 trial -
irbesartan
LIGAND PHARMACEUTICALS INC
Hypertension
1 trial
Frequently asked questions
How many clinical projects does LIGAND PHARMACEUTICALS have?
22 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.